Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Amyloidosis × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 104 Carcinoma, Non-Small-Cell Lung 54 Lung Neoplasms 24 Hodgkin Disease 14 Lymphoma 10 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 7 Neoplasms 7 Recurrence 6 Neoplasm Metastasis 6 Small Cell Lung Carcinoma 5 Lymphoma, Large B-Cell, Diffuse 5 Sarcoma 4 Rhabdomyosarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Breast Neoplasms, Male 4 Ovarian Neoplasms 3 NSCLC 3 Multiple Myeloma 3 Mesothelioma, Malignant 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Esophageal Squamous Cell Carcinoma 3 Burkitt Lymphoma 3 Brain Neoplasms 3

Interventions

Dexamethasone 13 Calcium Dobesilate 7 Melphalan 6 Lenalidomide 5 Cyclophosphamide 5 Bortezomib 5 pomalidomide 2 Thalidomide 2 Doxycycline 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 venetoclax 1 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 belantamab mafodotin 1 auricularum 1 Vinorelbine 1 Technetium Tc 99m Pyrophosphate 1 Technetium 1 Tacrolimus 1 Surveys and Questionnaires 1 Interleukin-2 1 Hyaluronoglucosaminidase 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Etoposide 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02791373 2018-04-03

ViGeM

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡